Get the Stockscreener App
0.45
5.42%
-0.0258
Tilray Brands Inc stock is traded at $0.45, with a volume of 44.00M.
It is down -5.42% in the last 24 hours and down -30.18% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
See More
Previous Close:
$0.4758
Open:
$0.4683
24h Volume:
44.00M
Relative Volume:
1.16
Market Cap:
$485.28M
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-1.50
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
-10.96%
1M Performance:
-30.18%
6M Performance:
-71.34%
1Y Performance:
-73.84%
1-Day Range:
$0.43
$0.4838
1-Week Range:
$0.43
$0.52
52-Week Range:
$0.43
$2.515
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.45 | 485.28M | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Tilray (NASDAQ:TLRY) Stock Price Down 1%Time to Sell? - MarketBeat
Tilray (TLRY) Launches New Ready-to-Drink Cocktails Cruisies - GuruFocus
Tilray (TLRY) Proposes Reverse Stock Split Amid Market Challenges - GuruFocus
(TLRY) Advanced Equity Analysis (TLRY:CA) - news.stocktradersdaily.com
Tilray Brands proposes reverse stock split - MSN
This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More - Benzinga
Cannabis company Tilray Brands proposes a reverse stock split - Bowen Island Undercurrent
Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails - GlobeNewswire
Struggling Cannabis Firm Tilray Brands (TLRY) Plans Reverse Stock Split - markets.businessinsider.com
Tilray Medical Introduces Cannabis Edibles in Australia - mg Magazine
Tilray Brands (NasdaqGS:TLRY) Schedules Special Meeting to Consider Reverse Stock Split - Yahoo Finance
Why Cannabis Co. Tilray (TLRY) Is Trading Down Today - Benzinga
Vegan, Sugar-Free, And Now In Australia: Tilray's Edibles Aren't Your Average Medical Launch - Benzinga
Tilray stock plunges to 52-week low at $0.44 By Investing.com - Investing.com India
Tilray Proposes Reverse Stock Split To Maintain Nasdaq Compliance And Cut Costs - Nasdaq
Tilray’s stock has been below $1 for months. Here’s how it plans to fix that. - MSN
Tilray Brands announces proposed reverse stock split and corresponding special meeting of stockholders - StratCann
Tilray Brands Announces Proposed Reverse Stock Split - Cannabis Business Times
Tilray (TLRY) Launches New Cruisies Cocktails for Summer in Northeast | TLRY Stock News - GuruFocus
Tilray (TLRY) Launches First Medical Cannabis Edibles in Australia | TLRY Stock News - GuruFocus
Form PRE 14A Tilray Brands, Inc. For: Jun 10 - StreetInsider
Tilray proposes reverse split to drive share price higher - Green Market Report
Tilray Makes Bold Move into Premium RTD Cocktails with New Cruisies LineSee First Products - Stock Titan
Tilray Brands Subsidiary Introduces Cannabis Edibles in Australia; Tilray Seeks Approval for Reverse Stock Split - marketscreener.com
Tilray Medical Breaks Ground: Introduces First-Ever Cannabis Edibles for Australian PatientsSee Product Line - Stock Titan
Tilray (TLRY) Proposes Reverse Stock Split Amid Strategic Adjustments - GuruFocus
Cannabis Company Tilray Brands Proposes A Reverse Stock Split - Barchart.com
Tilray plans reverse stock split to retain Nasdaq listing - Investing.com Australia
Tilray to Seek Approval for Reverse Stock Split at Stockholders' Meeting - MarketScreener
Tilray plans reverse stock split to retain Nasdaq listing By Investing.com - Investing.com India
Tilray (TLRY) Proposes Reverse Stock Split to Enhance Market Position | TLRY Stock News - GuruFocus
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders | TLRY Stock News - GuruFocus
Tilray Brands falls on reverse stock split plan - TradingView
Tilray Brands proposes reverse stock split (TLRY:NASDAQ) - Seeking Alpha
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders - GlobeNewswire
Tilray's Strategic Reverse Split Comes With $76M Debt Reduction and Strong $248M Cash Position - Stock Titan
(TLRY) Investment Strategy and Analysis (TLRY:CA) - news.stocktradersdaily.com
Tilray Brands (TLRY) Shows Strong Cannabis Segment Growth - GuruFocus
Alliance Global Partners Predicts Weaker Earnings for Tilray - MarketBeat
Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States - GlobeNewswire
Tilray (NASDAQ:TLRY) Trading Down 3%Time to Sell? - MarketBeat
Tilray FY2025 EPS Decreased by Alliance Global Partners - MarketBeat
Is Tilray Brands Inc. (NASDAQ:TLRY) the Best Penny Stock to Invest in Under $1? - Insider Monkey
3 Crashing Stocks I Wouldn't Buy Right Now - The Globe and Mail
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
0.74%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):